Ticker Details
Black Diamond Therapeutics, Inc.
IPO Date:	January 31, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$107.73M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.36 | 4.16%
Avg Daily Range (30 D):	$0.07 | 3.54%
Avg Daily Range (90 D):	$0.11 | 4.32%

Institutional Daily Volume
Avg Daily Volume:	.77M
Avg Daily Volume (30 D):	1.69M
Avg Daily Volume (90 D):	1.28M

Trade Size
Avg Trade Size (Sh.):	148
Avg Trade Size (Sh.) (30 D):	194
Avg Trade Size (Sh.) (90 D):	172

Institutional Trades
Total Institutional Trades:	386
Avg Institutional Trade:	$1.8M
Avg Institutional Trade (30 D):	$2.29M
Avg Institutional Trade (90 D):	$1.31M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.24M
Avg Closing Trade (30 D):	$2.29M
Avg Closing Trade (90 D):	$1.79M
Avg Closing Volume:	208.78K

News

May 26, 2026 @ 3:31 PM What's Going On With Black Diamond Therapeutics St... Source: Lekha Gupta

May 22, 2026 @ 12:00 PM Black Diamond Therapeutics to Participate in Jeffe... Source: Na

Aug 7, 2025 @ 12:23 PM Black Diamond (BDTX) Q2 Loss Narrows 47% Source: Jesterai

Aug 1, 2025 @ 4:21 PM Clarus (CLAR) Q2 Loss Beats Estimates Source: Jesterai

Mar 19, 2025 @ 11:00 AM Servier and Black Diamond Therapeutics AnnounceÂÂ... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.77	$-.16	$-.27
Diluted EPS	$-.76	$-.16	$-.26
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-43.21M	$-9.04M	$-15.12M
Operating Income / Loss	$-53.27M	$-11.26M	$-17.61M
Cost of Revenue
Net Cash Flow	$-68.34M	$9.08M	$-9.87M
PE Ratio